Immunity to tetanus is protective against the development of multiple sclerosis

Medical Hypotheses

Volumn 65, Issue 5, 2005, Pages 966-969

  Verstraeten, T ^a,d,e   Davis, R ^b   DeStefano, F ^c  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c CENTERS FOR DIS CONTR AND PREV   (United States)

^d NONE   (Belgium)

^e GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

TETANUS TOXOID;

ALLERGIC ENCEPHALOMYELITIS; AUTOIMMUNITY; CELLULAR IMMUNITY; DISEASE COURSE; GENDER; GEOGRAPHY; HUMAN; HUMORAL IMMUNITY; IMMUNITY; LABORATORY; MEDICAL LITERATURE; MULTIPLE SCLEROSIS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SOCIOECONOMICS; TETANUS; TETANUS PROPHYLAXIS; ARTICLE; BIOLOGICAL MODEL; BYSTANDER EFFECT; CLINICAL TRIAL; DISEASE PREDISPOSITION; DRUG EFFECT; IMMUNOLOGY; INCIDENCE; INNATE IMMUNITY; INTERNATIONAL COOPERATION; PREVALENCE; STATISTICS; VACCINATION;

ANIMALIA;

BYSTANDER EFFECT; CLINICAL TRIALS; DISEASE SUSCEPTIBILITY; HUMANS; IMMUNITY, NATURAL; INCIDENCE; INTERNATIONALITY; MODELS, IMMUNOLOGICAL; MULTIPLE SCLEROSIS; PREVALENCE; TETANUS TOXOID; VACCINATION;

EID: 27244455889     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2005.05.009     Document Type: Article

References (29)

1. J.H. Noseworthy, C. Lucchinetti, M. Rodriguez, and B.G. Weinshenker Multiple sclerosis New Engl J Med 343 2000 938 952
2. J. Murray Infection as a cause of multiple sclerosis (editorial) BMJ 325 2002 1128
3. J.F. Bach The effect of infections on susceptibility to autoimmune and allergic diseases New Engl J Med 347 2002 911 920
4. C. Braun-Fahrländer, J. Riedler, and U. Herz Environmental exposure to endotoxin and its relation to asthma in school-age children New Engl J Med 347 2002 869 877
5. R. Veronesi, A. Correia, and H. Ferreira Naturally acquired immunity: further evidence in humans and animals Proceedings of the fourth international conference on tetanus; 1975 April 6-12; Dakar, Senegal 1975 Fondation Merieux Lyon 613 626
6. B.J. Vakil, T.H. Tulpule, S.S. Rao, and M.B. Borker A comparison of 1500 units and 5000 units of tetanus antitoxin in simultaneous active and passive immunization against tetanus Indian J Med Res 56 1968 1188 1201
7. F.D. Dastur, V.P. Awatramani, and S.K. Dixit Response to single dose of tetanus vaccine in subjects with naturally acquired tetanus antitoxin Lancet 8240 1981 219 222
8. H. Matzkin, and S. Regev Naturally acquired immunity to tetanus toxin in an isolated community Infect Immun 48 1985 267 268
9. R. Veronesi, B. Bizzini, and R. Focaccia Naturally acquired antibodies to tetanus toxin in humans and animals from the Galapagos islands J Infect Dis 147 1983 308 311
10. A. Commalo-Malo L'immunité antitétanique chez les non vaccinés Proceedings of the fourth international conference on tetanus; 1975 April 6-12; Dakar, Senegal 1975 Fondation Merieux Lyon 675 678
11. F.E. Udawdia Tetanus 1994 Oxford University Press Bombay
12. C. Confavreux, S. Suissa, P. Saddier, V. Bourdes, and S. Vukusic Immunizations and the risk of relapse in multiple sclerosis New Engl J Med 344 2001 319 326
13. I. Casetta, E. Granieri, and S. Malagu Environmental risk factors and multiple sclerosis: a community-based, case-control study in the province of Ferrara, Italy Neuroepidemiology 13 1994 120 128
14. J.F. Kurtzke, and W.F. Page Epidemiology of multiple sclerosis in US veterans: VII. Risk factors for MS Neurology 48 1997 204 213
15. N. Zilber, and E. Kahana Risk factors for multiple sclerosis: a case-control study in Israel Acta Neurol Scand 94 1996 395 403
16. M. Alter, and J. Speer Clinical evaluation of possible etiologic factors in multiple sclerosis Neurology 18 1968 109 116
17. D.A. Compston, B.N. Vakarelis, E. Paul, W.I. McDonald, J.R. Batchelor, and C.A. Mims Viral infection in patients with multiple sclerosis and HLA-DR matched controls Brain 109 1986 325 344
18. F. DeStefano, T. Verstraeten, and L.A. Jackson Vaccinations and risk of central nervous system demyelinating diseases in adults Arch Neurol 60 2003 504 509
19. M. Hernan, S. Jick, M. Olek, and H. Sick Hepatitis B vaccine and the risk of multiple sclerosis: a prospective study Neurology 63 2004 838 842
20. Verstraeten T, Davis R, DeStefano F and The Vaccine Safety Datalink Team. Decreased risk of demyelinating disease following tetanus immunization. In: Proceedings of the 35th Annual SER meeting, Palm Desert, California, USA; 2002.
21. J.F. Kurtzke, K. Hyllested, and J.D. Arbuckie Multiple sclerosis in the Faroe Islands. 7. Results of a case-control questionnaire with multiple sclerosis Acta Neurol Scand 96 1997 149 157
22. S. Bansil, B.S. Singhal, and G.K. Ahula Multiple sclerosis in India: a case-control study of environmental exposures Acta Neurol Scand 95 1997 90 95
23. G. Lamoureux, N. Giard, R. Jolicoeur, V. Toughlian, and M. Desrosiers Immunological features in multiple sclerosis Br Med J 1 1976 183 186
24. N.F. Moriabadi, S. Niewisk, and N. Kruse Influence of immunization in MS, absence of T-cell response against white matter proteins Neurology 56 2001 938 943
25. K. Stark, C. Schonfeld, J. Barg, B. Molz, A. Vornwald, and U. Bienzle Seroprevalence and determinants of diphtheria, tetanus and poliomyelitis antibodies among adults in Berlin, Germany Vaccine 17 1999 844 850
26. G.M. McQuillan, D. Kruszon-Moran, A. Deforest, S. Chu, and M. Wharton Serologic immunity to diphtheria and tetanus in the United States Ann Int Med 136 2002 660 666
27. Veronesi Tetanus: important new concepts 1981 Excerpta Medica Amsterdam
28. J.F. Bach Protective role of infections and vaccinations on autoimmune diseases J Autoimmun 16 2001 347 353
29. W.A. Sibley, C.R. Banford, K. Clark, M.S. Smith, and J.F. Laguna A prospective study of physical trauma and multiple sclerosis J Neurol Neurosurg Psychiat 54 1991 584 589